592 related articles for article (PubMed ID: 27435502)
1. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
Bertoli G; Cava C; Castiglioni I
Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer.
Asghari F; Haghnavaz N; Baradaran B; Hemmatzadeh M; Kazemi T
Biomed Pharmacother; 2016 Jul; 81():305-317. PubMed ID: 27261608
[TBL] [Abstract][Full Text] [Related]
8. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
O'Bryan S; Dong S; Mathis JM; Alahari SK
Eur J Cancer; 2017 Feb; 72():1-11. PubMed ID: 27997852
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
Zhang K; Zhang Y; Liu C; Xiong Y; Zhang J
Int J Oncol; 2014 Sep; 45(3):950-8. PubMed ID: 24913679
[TBL] [Abstract][Full Text] [Related]
10. The Dual Regulatory Role of MiR-181a in Breast Cancer.
Yang C; Tabatabaei SN; Ruan X; Hardy P
Cell Physiol Biochem; 2017; 44(3):843-856. PubMed ID: 29176320
[TBL] [Abstract][Full Text] [Related]
11. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.
Goh JN; Loo SY; Datta A; Siveen KS; Yap WN; Cai W; Shin EM; Wang C; Kim JE; Chan M; Dharmarajan AM; Lee AS; Lobie PE; Yap CT; Kumar AP
Biol Rev Camb Philos Soc; 2016 May; 91(2):409-28. PubMed ID: 25631495
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
Asiaf A; Ahmad ST; Arjumand W; Zargar MA
Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
Petrović N; Nakashidze I; Nedeljković M
J Mammary Gland Biol Neoplasia; 2021 Jun; 26(2):157-178. PubMed ID: 33479880
[TBL] [Abstract][Full Text] [Related]
14. Small players with big roles: microRNAs as targets to inhibit breast cancer progression.
Greene SB; Herschkowitz JI; Rosen JM
Curr Drug Targets; 2010 Sep; 11(9):1059-73. PubMed ID: 20545613
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
16. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.
van Schooneveld E; Wildiers H; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2015 Feb; 17():21. PubMed ID: 25849621
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
[TBL] [Abstract][Full Text] [Related]
19. Implication of miRNA in the diagnosis and treatment of breast cancer.
Castañeda CA; Agullo-Ortuño MT; Fresno Vara JA; Cortes-Funes H; Gomez HL; Ciruelos E
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1265-75. PubMed ID: 21916580
[TBL] [Abstract][Full Text] [Related]
20. Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.
Hannafon BN; Ding WQ
Am J Pathol; 2019 May; 189(5):966-974. PubMed ID: 30273605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
